Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1998 | 03-1998 | 12-1997 | 09-1997 | 06-1997 | |
| Sales | 2,340,700 | 2,269,100 | 2,258,000 | 2,160,100 | 1,998,700 |
| Cost of Goods | 626,100 | 602,100 | 685,000 | 587,800 | 548,800 |
| Gross Profit | 1,714,600 | 1,667,000 | 1,730,800 | 1,572,300 | 1,439,900 |
| Operating Expenses | 1,072,900 | 930,800 | 1,091,500 | 933,400 | 900,200 |
| Operating Income | 641,800 | 736,300 | 481,500 | 639,700 | 550,500 |
| Interest Expense | 43,100 | 48,600 | 53,700 | 57,300 | 62,500 |
| Other Income | 56,400 | 16,700 | 182,200 | 29,900 | -1,776,900 |
| Pre-tax Income | 655,100 | 704,400 | 610,000 | 612,300 | -1,288,900 |
| Income Tax | 163,800 | 176,100 | 152,500 | 155,400 | 443,200 |
| Net Income Continuous | 491,300 | 528,300 | 465,100 | 456,900 | -1,732,100 |
| Net Income Discontinuous | 0 | -7,200 | -7,600 | 0 | 0 |
| Net Income | $491,300 | $521,100 | $457,500 | $456,900 | $-1,732,100 |
| EPS Basic Total Ops | 0.45 | 0.47 | 0.41 | 0.41 | -1.57 |
| EPS Basic Continuous Ops | 0.45 | 0.48 | 0.42 | 0.41 | -1.57 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | -0.01 | N/A | N/A |
| EPS Diluted Total Ops | 0.44 | 0.46 | 0.40 | 0.41 | -1.57 |
| EPS Diluted Continuous Ops | 0.45 | 0.48 | 0.41 | 0.41 | -1.57 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | -0.01 | N/A | N/A |
| EBITDA(a) | $759,000 | $855,500 | $591,500 | $764,500 | $686,500 |